Polymorphisms within the F7, ATP9B, MAP3K13 and ZNF320 genes have not been suggested previously as contributing to AD risk, despite multiple large-scale GWAS studies[1, 58–65]. This evidence concerns the gene ATP9B and Alzheimer disease.